{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:32:29Z","timestamp":1790548349614,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Science and Technology Major Project","award":["2014ZX09J14101-05C"],"award-info":[{"award-number":["2014ZX09J14101-05C"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.neuropharm.2017.02.022","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T16:16:31Z","timestamp":1487952991000},"page":"352-363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Neuroprotective effects of Kukoamine A on neurotoxin-induced Parkinson's model through apoptosis inhibition and autophagy enhancement"],"prefix":"10.1016","volume":"117","author":[{"given":"XiaoLong","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DanDan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WeiHong","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8973-2384","authenticated-orcid":false,"given":"QingChun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.02.022_bib1","first-page":"743","article-title":"Current approaches to the treatment of parkinson's disease","volume":"4","author":"Jankovic","year":"2008","journal-title":"Neuropsych. Dis."},{"key":"10.1016\/j.neuropharm.2017.02.022_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0006-8993(90)90576-W","article-title":"Evaluation of a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated C57 black mouse model for parkinsonism","volume":"515","author":"Arai","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2017.02.022_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.exger.2006.05.019","article-title":"Chaperone-mediated autophagy in aging and neurodegeneration: lessons from \u03b1-synuclein","volume":"42","author":"Bandhyopadhyay","year":"2007","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.neuropharm.2017.02.022_bib5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0091-3057(95)00108-9","article-title":"Striatal dopamine-mediated motor behavior is altered following occlusion of the middle cerebral artery","volume":"52","author":"Borlongan","year":"1995","journal-title":"Pharmacol. Biochem."},{"key":"10.1016\/j.neuropharm.2017.02.022_bib6","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/jnr.23061","article-title":"Naphthazarin has a protective effect on the 1-methyl-4-phenyl-1, 2, 3, 4-tetrahydropyridine-induced parkinson's disease model","volume":"90","author":"Choi","year":"2012","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2017.02.022_bib7","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1126\/science.1101738","article-title":"Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy","volume":"305","author":"Cuervo","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2017.02.022_bib8","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0040-4039(00)74574-6","article-title":"Structure of kukoamine a, a hypotensive principle of lycium chinense root barks1","volume":"21","author":"Funayama","year":"1980","journal-title":"Tetrahedron. Lett."},{"key":"10.1016\/j.neuropharm.2017.02.022_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bbagen.2014.11.006","article-title":"Neuroprotection by Kukoamine A against oxidative stress may involve N-methyl-d-aspartate receptors. BBA-Gen","volume":"1850","author":"Hu","year":"2015","journal-title":"Subjects"},{"key":"10.1016\/j.neuropharm.2017.02.022_bib11","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1093\/emboj\/19.21.5720","article-title":"LC3, a mammalian homologue of yeast apg8p, is localized in autophagosome membranes after processing","volume":"19","author":"Kabeya","year":"2000","journal-title":"Embo. J."},{"key":"10.1016\/j.neuropharm.2017.02.022_bib12","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1126\/science.290.5497.1717","article-title":"Autophagy as a regulated pathway of cellular degradation","volume":"290","author":"Klionsky","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2017.02.022_bib13","doi-asserted-by":"crossref","first-page":"514095","DOI":"10.1155\/2013\/514095","article-title":"Gastrodin protects apoptotic dopaminergic neurons in a toxin-induced Parkinson's disease model","volume":"2013","author":"Kumar","year":"2013","journal-title":"Evid-Based. Compl. Alt."},{"key":"10.1016\/j.neuropharm.2017.02.022_bib14","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2017.02.022_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.neuropharm.2017.02.022_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.neuro.28.061604.135718","article-title":"Molecular pathophysiology of parkinson's disease","volume":"28","author":"Moore","year":"2005","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.022_bib17","first-page":"1081","article-title":"Phosphodiesterase 7 inhibition preserves dopaminergic neurons in cellular and rodent models of parkinson disease","volume":"6","author":"Moralesgarcia","year":"2011","journal-title":"Plos One"},{"key":"10.1016\/j.neuropharm.2017.02.022_bib18","first-page":"985157","article-title":"Magnolol protects against MPTP\/MPP(+)-induced toxicity via inhibition of oxidative stress in in\u00a0vivo and in\u00a0vitro models of parkinson's disease","volume":"2012","author":"Muroyama","year":"2012","journal-title":"Park. Dis-us"},{"key":"10.1016\/j.neuropharm.2017.02.022_bib19","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.neurobiolaging.2014.01.028","article-title":"Neuroprotective effects of mesenchymal stem cells through autophagy modulation in a parkinsonian model","volume":"35","author":"Park","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2017.02.022_bib20","first-page":"675","article-title":"Understanding dopaminergic cell death pathways in parkinson disease","volume":"4","author":"Patrick","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.02.022_bib21","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1172\/JCI29178","article-title":"Diagnosis and treatment of parkinson disease: molecules to medicine","volume":"116","author":"Savitt","year":"2006","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.neuropharm.2017.02.022_bib22","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0304-4165(90)90039-Y","article-title":"Esr studies of stearic acid binding to bovine serum albumin","volume":"1036","author":"Shenkar","year":"1990","journal-title":"BBA-Gen. Subj."},{"key":"10.1016\/j.neuropharm.2017.02.022_bib23","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2174\/1566524016666160523143757","article-title":"Cortex lycii radicis extracts protect pancreatic beta cells under high glucose conditions","volume":"6","author":"Wang","year":"2016","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.neuropharm.2017.02.022_bib24","doi-asserted-by":"crossref","first-page":"49676","DOI":"10.1074\/jbc.M208756200","article-title":"Protein kinase b\/akt prevents fatty acid-induced apoptosis in pancreatic beta-cells (ins-1)","volume":"277","author":"Wrede","year":"2002","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.02.022_bib25","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1007\/s11064-016-1967-0","article-title":"Neuroprotective effects of kukoamine a against radiation-induced rat brain injury through inhibition of oxidative stress and neuronal apoptosis","volume":"41","author":"Zhang","year":"2016","journal-title":"Neurochem. Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300783?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300783?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T19:11:51Z","timestamp":1587409911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817300783"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":23,"alternative-id":["S0028390817300783"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.02.022","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroprotective effects of Kukoamine A on neurotoxin-induced Parkinson's model through apoptosis inhibition and autophagy enhancement","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.02.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}